Dublin, Ireland: UPS Healthcare is to open a site in Dublin next year which will include the handling of cold chain management services.
Opening in late 2023, the new facility will boast nearly 6,000 m² of healthcare-dedicated space to connect Ireland’s growing pharmaceutical and medical technology industries to UPS’s global logistics network that serves customers in over 220 countries and territories.
The announcement comes at a time when 80% of pharmaceutical drugs in the European Union require cold-chain logistical support and temperature-controlled transport. More than 50% of all new drugs in the global pharmaceutical pipeline are cutting edge biomedical drugs – such as vaccines – that tend to be temperature-sensitive.
Cathy O’Brien, UPS Healthcare’s vice president for international sales, said: “This is a significant investment by UPS in Ireland and a demonstration of our commitment to enabling truly global healthcare supply chains.
“Our new facility supports the quality and regulatory needs of manufacturers, many of whom are providing critical upstream activity, and we provide them with resiliency and scale. UPS Healthcare is now offering the first truly dedicated freight, small parcel and logistics offering in Ireland, including cold chain management services. Ireland is a world leader in research, biologics and healthcare innovation, and we are confident that our clinical to commercial service offering will drive value for the Irish healthcare and economic ecosystem in the years to come.”
UPS recently announced its planned acquisition of the Bomi Group, which has temperature-controlled sites in 14 countries in Europe and Latin America.
UPS Healthcare has also expanded its specialised temperature-controlled fleet across Benelux and Italy. This expansion adds to existing cold chain transport services in Italy, Hungary, the UK, and Poland.
